Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Persona Ti-Nidium Post-Market Clinical Follow-up

NCT: NCT04817969 · ACTIVE_NOT_RECRUITING

NCT IDNCT04817969
StatusACTIVE_NOT_RECRUITING
Start Date2021-06-01
Completion2034-05
SponsorZimmer Biomet (INDUSTRY)
First posted
Last updated

Brief Summary

The main objectives of this study are to evaluate overall clinical performance and safety of the Persona Ti-Nidium implant in total knee arthroplasty.

Frequently Asked Questions

What is Persona Ti-Nidium Post-Market Clinical Follow-up?

Persona Ti-Nidium Post-Market Clinical Follow-up is a clinical trial registered under NCT04817969. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04817969?

The current status of NCT04817969 (Persona Ti-Nidium Post-Market Clinical Follow-up) is: ACTIVE_NOT_RECRUITING.

When did Persona Ti-Nidium Post-Market Clinical Follow-up start?

Persona Ti-Nidium Post-Market Clinical Follow-up started on 2021-06-01.

Related Devices

K243293Zimmer® Persona® Personalized Knee SystemZimmer Biomet K251834Persona Partial KneeZimmer Biomet K243571Trabecular Metal Acetabular Revision System, Acetabular Liners and Constrained LinersZimmer Biomet K251620A.L.P.S. Proximal Humerus Plating SystemZimmer Biomet K242543Persona the Personalized Knee System (Persona Ti-Nidium PPS Femurs)Zimmer, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑